Editorial

---

Role of telemedicine in treatment of pediatric type 1 diabetes

CellR4 2020; 8: e2881
DOI: 10.32113/cellr4_20207_2881

Editorial – Potential risks of the SARS-related coronavirus 2 infection [COVID-19] in pregnancy

CellR4 2020; 8: e2846
DOI: 10.32113/cellr4_20205_2846

Editorial – COVID-19 pandemic: is it time to learn about DPP-4/CD26?

CellR4 2020; 8: e2835
DOI: 10.32113/cellr4_20204_2835

Islet cell autotransplantation update

CellR4 2019; 7: e2609
DOI: 10.32113/cellr4_20194_2609

Can high-dose omega-3 fatty acids and high-dose vitamin D3 (cholecalciferol) prevent type 1 diabetes and sustain preservation of beta-cell function after disease onset?

CellR4 2018; 6 (1): e2493

Editorial – Improving the regulatory framework for cell therapy does not equate to deregulation

CellR4 2016; 4 (4): e2109

Hypes, hopes and translational challenges on the path to cures

CellR4 2016; 4 (2): e1810

The Cure Alliance is officially a 501(c)3 supporter membership surges past 50,000

CellR4 2016; 4 (2): e1801

The Fight to Flip the Master Switch: A Dispatch from the Battlefield of Discovery

CellR4 2015; 3 (4): e1620

Treatment Options in Insulin-Dependent Diabetes and the Developing Paradigm Shift from Metabolic to Immunologic Therapy for New-Onset Type 1 Diabetes

CellR4 2015; 3 (3): e1585

You Will Always Be With Us, Carl-Gustav

CellR4 2014; 2 (2): e910